| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |